Tech Company Financing Transactions
ALDEA Pharma Funding Round
On 11/19/2013, ALDEA Pharma raised $11.4 million in financing from private investors.
Transaction Overview
Company Name
Announced On
11/19/2013
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$11,380,718
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3696 Haven Ave. C
Redwood City, CA 94566
USA
Redwood City, CA 94566
USA
Phone
Website
Email Address
Overview
ALDEA Pharmaceuticals develops small-molecule modulators of the ALDH family for the treatment of toxic aldehyde-related diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Yelle
Chief Medical Officer
Richard Shames
VP - R & D
Wenjin Yang
Browse more venture capital transactions:
Prev: 11/19/2013: Wireless Seismic venture capital transaction
Next: 11/19/2013: Therma-Flite venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs